Adagio Medical Prices Up to $50M Private Placement
Adagio Medical Announces Up to $50 Million Private Placement to Advance Cardiac Arrhythmia Therapies Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or the “Company”), a leading innovator in the development…
City of Hope Honors Tom Corson with Michael Bublé Performance and Cher Appearance
Music Industry Icons Unite to Celebrate Tom Corson at City of Hope’s Spirit of Life Gala, Raising Funds to Advance Cancer Research, Survivorship Programs, and Integrative Therapies one of the…
TP et l’UNICEF Renouvellement de Partenariat Humanitaire
TP and UNICEF Renew Partnership to Advance Education and Humanitarian Support Globally TP (formerly Teleperformance), a global leader in enterprise digital solutions, and UNICEF have announced the renewal of their…
SelectQuote Research Reveals Critical Gaps in Healthcare, Urges Personalized Solutions
SelectQuote Research Reveals Critical Gaps in Medicare Care, Underscoring Need for Personalized Healthcare Solutions OVERLAND PARK, Kan.–(BUSINESS WIRE)–SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and the…
Viatris Acquires Aculys Pharma, Securing Pitolisant and Spydia® Rights in Japan & Asia-Pacific
Viatris Expands CNS Portfolio in Japan with Acquisition of Aculys Pharma, Gaining Exclusive Rights to Pitolisant and Spydia® Viatris Inc. (Nasdaq: VTRS), a leading global healthcare company, today announced the…
WuXi Biologics Celebrates Sonoma Biotherapeutics’ Fred Ramsdell, PhD, 2025 Nobel Laureate
Transforming Autoimmune and Inflammatory Disease Therapies WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), proudly congratulates Dr. Fred Ramsdell, PhD, co-founder and Chair of the…
Taiho Pharma Licenses PI3Kα Inhibitor Risovalisib (CYH33) to Haihe Biopharma
Taiho Pharmaceutical Grants Exclusive Rights for PI3Kα Inhibitor Risovalisib (CYH33) to Haihe Biopharma Taiho Pharmaceutical Co., Ltd. (“Taiho”) and Haihe Biopharma Co., Ltd. (“Haihe”) today announced the signing of an…
argenx to Showcase Immunology Advances at 2025 AANEM and MGFA Meetings
argenx to Present Comprehensive Immunology Data at 2025 AANEM Annual Meeting and MGFA Scientific Session argenx SE (Euronext & Nasdaq: ARGX), a global immunology company dedicated to improving the lives…
CLARITY Study: 90% Prefer Long-Acting Cabotegravir Over Lenacapavir for HIV
ViiV Healthcare CLARITY Study Shows Cabotegravir Long-Acting Injections More Acceptable and Preferred Over Lenacapavir GSK plc (LSE/NYSE: GSK) announced today that ViiV Healthcare, the global specialist HIV company majority owned…
Zoetis Receives Health Canada Approval for Lenivia® to Treat Osteoarthritis Pain in Dogs
Zoetis Receives Health Canada Approval for Lenivia® to Relieve Osteoarthritis Pain in Dogs Zoetis Inc. today announced that Health Canada has approved Lenivia® (izenivetmab injection) for the treatment of pain…
Regeneron Highlights Oncology Pipeline Progress at ESMO 2025
Regeneron Unveils Key Oncology Pipeline Updates at ESMO 2025, Highlighting Patient-Centric Approaches for Hard-to-Treat Cancers Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that new and updated data from its oncology…
CVS Pharmacy Finalizes Nationwide Acquisition of Rite Aid Assets
CVS Pharmacy Finalizes Nationwide Acquisition of Rite Aid and Bartell Drugs Assets, Expanding Access to Care Across the U.S. CVS Pharmacy, a subsidiary of CVS Health, today announced the successful…